GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GenFleet Therapeutics (Shanghai) 2595.HK · HKD

N/A · HKEX · 🇭🇰 Hong Kong

Compare

22.52

+3.30%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2024

Revenue

CN¥104.7m

FY2023FY2024

Net income

−CN¥677.6m

FY2023FY2024

Free cash flow

−CN¥206.6m

FY2023FY2024

Shareholders' equity

−CN¥1.96bn

FY2023FY2024

Income statement

Fiscal years

FY2024FY2023
RevenueCN¥104.7mCN¥73.7m
Research and developmentCN¥332.1mCN¥312.7m
Operating income−CN¥298.7m−CN¥267.9m
Net income−CN¥677.6m−CN¥508.3m
Diluted earnings per share-1.96-1.47

Balance sheet

At each fiscal year end

FY2024FY2023
Total assetsCN¥606.8mCN¥536.1m
Cash and short-term investmentsCN¥394.9mCN¥332.2m
Total liabilitiesCN¥2.56bnCN¥1.85bn
DebtCN¥69.3mCN¥31.7m
Shareholders' equity−CN¥1.96bn−CN¥1.32bn
Shares outstanding345m345m

Cash flow

Fiscal years

FY2024FY2023
Cash from operations−CN¥206.4m−CN¥202.1m
Capital spending−CN¥236,000−CN¥594,000
Free cash flow−CN¥206.6m−CN¥202.7m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024
RevenueCN¥88.7mCN¥104.7m—
Operating income−CN¥79.7m−CN¥298.7m−CN¥193.2m
Net income−CN¥698.6m−CN¥677.6m−CN¥449.3m
Diluted earnings per share-2.02-1.96-1.30
Cash from operations−CN¥50.0m−CN¥43.0m−CN¥162.0m
Total assetsCN¥551.9m——
Cash and short-term investmentsCN¥366.5m——
DebtCN¥90.6m——
Shareholders' equity−CN¥2.64bn——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.